Anaptysbio (ANAB) Assets (2016 - 2026)
Anaptysbio (ANAB) reported Assets of $329.68 million for Q1 2026, down 21.9% from $422.05 million a year earlier and down 9.5% from the prior quarter.
Powered by 
Analysis
Anaptysbio (ANAB) Assets (2016 - 2026) Analysis & Trends
At the end of FY2025, Anaptysbio posted Assets of $364.4 million, down 24.7% from FY2024.
- Assets has a five-year compound annual growth rate of -2.6% (FY2020 to FY2025).
- By year, Assets came in at $483.83 million in FY2024 (+7.0%), $452.39 million in FY2023 (-25.9%), $610.38 million in FY2022 (-5.1%) and $643.07 million in FY2021 (+54.4%).
- The Q1 2026 figure ranks as the lowest quarterly Assets since Q2 2018.
- Year over year, Assets has now declined in each of the last four quarters, with an average decline of 12.7% over the last eight quarters.
- The high point for year-over-year Assets in five years was Q1 2022 (growth of 57.7%); the low point was Q3 2025 (a decline of 28.4%).
- Per Business Quant data, the three quarters before Q1 2026 came in at $364.4 million (Q4 2025), $353.1 million (Q3 2025) and $335.25 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Anaptysbio | 1.47 Bn | 362.02 Mn | - | 329.68 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 329.68 Mn |
| Dec 31, 2025 | 364.40 Mn |
| Sep 30, 2025 | 353.10 Mn |
| Jun 30, 2025 | 335.25 Mn |
| Mar 31, 2025 | 422.05 Mn |
| Dec 31, 2024 | 483.83 Mn |
| Sep 30, 2024 | 493.42 Mn |
| Jun 30, 2024 | 427.38 Mn |
| Mar 31, 2024 | 405.84 Mn |
| Dec 31, 2023 | 452.39 Mn |
| Sep 30, 2023 | 487.33 Mn |
| Jun 30, 2023 | 517.10 Mn |
| Mar 31, 2023 | 551.79 Mn |
| Dec 31, 2022 | 610.38 Mn |
| Sep 30, 2022 | 618.50 Mn |
| Jun 30, 2022 | 603.85 Mn |
| Mar 31, 2022 | 625.17 Mn |
| Dec 31, 2021 | 643.07 Mn |
| Sep 30, 2021 | 424.34 Mn |
| Jun 30, 2021 | 426.57 Mn |
API Access
Anaptysbio Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=ANAB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "ANAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=ANAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();